AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionPrudential Plc
Latest Disclosed Ownership158,795 shares
Latest Disclosed Value $ 34,536,325
Prudential Plc reports 1.65% increase in ownership of ABBV / AbbVie Inc.

On May 14, 2026 - Prudential Plc filed a 13F-HR form disclosing ownership of 158,795 shares of AbbVie Inc. (US:ABBV) valued at $34,536,325 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 156,221 shares of AbbVie Inc.. This represents a change in shares of 1.65% during the quarter. The current value of the position is $34,479,158 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ABBVIE COM 00287Y109 158,795 2,574 1.65 34,536 -3.24 0.1490
2026-02-11 2025-12-31 13F ABBVIE COM 00287Y109 156,221 -319 -0.20 35,695 -1.52 0.2830
2025-11-14 2025-09-30 13F ABBVIE COM 00287Y109 156,540 -16,705 -9.64 36,245 12.71 0.2664
2025-08-12 2025-06-30 13F ABBVIE COM 00287Y109 173,245 -2,187 -1.25 32,158 -12.51 0.1939
2025-05-13 2025-03-31 13F ABBVIE COM 00287Y109 175,432 37,858 27.52 36,757 50.36 0.1840
2025-02-13 2024-12-31 13F ABBVIE COM 00287Y109 137,574 -26,926 -16.37 24,447 -24.75 0.1230
2024-11-13 2024-09-30 13F ABBVIE COM 00287Y109 164,500 3,164 1.96 32,485 17.39 0.1632
2024-08-07 2024-06-30 13F ABBVIE COM 00287Y109 161,336 15,051 10.29 27,672 3.88 0.1866
2024-05-14 2024-03-31 13F ABBVIE COM 00287Y109 146,285 -73,939 -33.57 26,638 -21.95 0.2030
2024-02-14 2023-12-31 13F ABBVIE COM 00287Y109 220,224 10,933 5.22 34,128 9.40 0.3462
2023-11-13 2023-09-30 13F ABBVIE COM 00287Y109 209,291 25,858 14.10 31,197 26.23 0.3467
2023-08-14 2023-06-30 13F ABBVIE COM 00287Y109 183,433 -7,388 -3.87 24,714 -18.74 0.2890
2023-05-12 2023-03-31 13F ABBVIE COM 00287Y109 190,821 -2,953 -1.52 30,411 -2.89 0.3570
2023-02-09 2022-12-31 13F ABBVIE COM 00287Y109 193,774 37,446 23.95 31,316 49.25 0.3931
2022-11-14 2022-09-30 13F ABBVIE COM 00287Y109 156,328 49,498 46.33 20,981 28.23 0.3320
2022-08-12 2022-06-30 13F ABBVIE COM 00287Y109 106,830 26,714 33.34 16,362 25.98 0.2962
2022-05-13 2022-03-31 13F ABBVIE COM 00287Y109 80,116 8,330 11.60 12,988 33.62 0.1878
2022-02-11 2021-12-31 13F ABBVIE COM 00287Y109 71,786 -3,949 -5.21 9,720 18.97 0.1331
2021-11-10 2021-09-30 13F ABBVIE COM 00287Y109 75,735 -164,738 -68.51 8,170 -69.84 0.1139
2021-08-13 2021-06-30 13F AbbVie AbbVie Inc 00287Y109 240,473 -665,297 -73.45 27,087 -72.37 0.2510
2021-05-14 2021-03-31 13F AbbVie AbbVie Inc 00287Y109 905,770 -446,578 -33.02 98,022 -32.35 0.6791
2021-02-10 2020-12-31 13F/A-1 AbbVie AbbVie Inc 00287Y109 1,352,348 -543,381 -28.66 144,904 -12.73 0.7696
2021-02-08 2020-12-31 13F AbbVie AbbVie Inc 00287Y109 1,352,348 -543,381 144,904 329,706.7352
2020-10-30 2020-09-30 13F AbbVie AbbVie Inc 00287Y109 1,895,729 -463,591 -19.65 166,047 -28.32 0.8269
2020-07-31 2020-06-30 13F AbbVie AbbVie Inc 00287Y109 2,359,320 143,770 6.49 231,638 37.22 1.1154
2020-05-01 2020-03-31 13F AbbVie AbbVie Inc 00287Y109 2,215,550 561,839 33.97 168,803 15.29 0.8999
2020-02-13 2019-12-31 13F AbbVie AbbVie Inc 00287Y109 1,653,711 -236,096 -12.49 146,419 2.28 0.6172
2019-11-12 2019-09-30 13F ABBVIE COM 00287Y109 1,889,807 -359,255 -15.97 143,154 -12.49 0.4211
2019-10-04 2019-06-30 13F/A-1 ABBVIE COM 00287Y109 2,249,062 -68,307 -2.95 163,582 -12.41 0.5001
2019-08-14 2019-06-30 13F ABBVIE COM 00287Y109 2,249,062 -68,307 163,582
2019-10-04 2019-03-31 13F/A-1 AbbVie COM USD0.01 00287Y109 2,317,369 69,098 3.07 186,757 -9.90 0.6725
2019-05-13 2019-03-31 13F AbbVie COM USD0.01 00287Y109 2,317,369 69,098 186,757
2019-10-04 2018-12-31 13F/A-1 AbbVie COM USD0.01 00287Y109 2,248,271 -151,373 -6.31 207,268 -8.68 0.8347
2019-02-13 2018-12-31 13F AbbVie COM USD0.01 00287Y109 2,248,271 -151,373 207,268
2019-10-03 2018-09-30 13F/A-1 AbbVie COM USD0.01 00287Y109 2,399,644 -285,626 -10.64 226,958 -8.78 0.7325
2018-11-14 2018-09-30 13F AbbVie COM USD0.01 00287Y109 2,399,644 -285,626 226,958
2018-08-14 2018-06-30 13F AbbVie COM USD0.01 00287Y109 2,685,270 263,488 10.88 248,790 8.54 0.7785
2018-05-15 2018-03-31 13F AbbVie COM USD0.01 00287Y109 2,421,782 -285,633 -10.55 229,222 -12.46 0.7156
2018-02-14 2017-12-31 13F AbbVie COM USD0.01 00287Y109 2,707,415 -1,903,018 -41.28 261,834 -36.09 0.7975
2017-11-14 2017-09-30 13F AbbVie COM USD0.01 00287Y109 4,610,433 -1,860,682 -28.75 409,682 -12.69 1.2926
2017-08-14 2017-06-30 13F AbbVie COM USD0.01 00287Y109 6,471,115 -550,777 -7.84 469,221 2.55 1.5376
2017-05-15 2017-03-31 13F AbbVie COM USD0.01 00287Y109 7,021,892 10,866 0.15 457,548 4.22 1.5336
2017-02-09 2016-12-31 13F AbbVie COM USD0.01 00287Y109 7,011,026 786,487 12.64 439,030 11.83 1.5436
2016-11-14 2016-09-30 13F AbbVie COM USD0.01 00287Y109 6,224,539 -740,707 -10.63 392,583 -8.96 1.4815
2016-08-09 2016-06-30 13F AbbVie COM USD0.01 00287Y109 6,965,246 -1,510,682 -17.82 431,218 -10.93 1.6923
2016-05-13 2016-03-31 13F AbbVie COM USD0.01 00287Y109 8,475,928 -639,594 -7.02 484,145 -10.34 1.9638
2016-02-12 2015-12-31 13F AbbVie COM USD0.01 00287Y109 9,115,522 -65,421 -0.71 540,004 8.10 2.1938
2015-11-13 2015-09-30 13F AbbVie COM USD0.01 00287Y109 9,180,943 -467,231 -4.84 499,535 -22.94 2.1349
2015-08-14 2015-06-30 13F AbbVie COM USD0.01 00287Y109 9,648,174 2,046,632 26.92 648,261 45.68 2.4748
2015-05-15 2015-03-31 13F AbbVie COM USD0.01 00287Y109 7,601,542 1,298,588 20.60 444,995 7.89 1.9630
2015-02-13 2014-12-31 13F AbbVie COM USD0.01 00287Y109 6,302,954 -642,672 -9.25 412,465 2.81 1.7479
2014-11-14 2014-09-30 13F AbbVie COM USD0.01 00287Y109 6,945,626 6,044,763 671.00 401,180 689.03 1.6597
2014-08-14 2014-06-30 13F AbbVie COM USD0.01 00287Y109 900,863 4,500 0.50 50,845 10.36 0.2120
2014-05-15 2014-03-31 13F AbbVie COM USD0.01 00287Y109 896,363 201,800 29.05 46,073 25.61 0.2049
2014-02-14 2013-12-31 13F ABBVIE COM 00287Y109 694,563 70,409 11.28 36,680 31.38 0.1571
2013-12-18 2013-09-30 13F/A-1 ABBVIE COM 00287Y109 624,154 311,300 99.50 27,919 115.86 0.1423
2013-11-15 2013-09-30 13F ABBVIE COM 00287Y109 624,154 27,919
2013-08-15 2013-06-30 13F ABBVIE COM 00287Y109 312,854 312,854 12,934 0.0700
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.